Here, we demonstrate a synthetic strategy based on the substitution of bridging ligands in soluble ... partial substitution can also occur and form mixed-ligand species that may be difficult ...

During the early phase of drug discovery, in silico receptor-based and ligand-based strategies are used to find novel hits. Pseudoreceptor models link the concepts of both strategies for ...

Chirik and Semproni achieved this change by treating hafno- and zirconocene complexes containing a highly activated, side-on bound bridging N–N ligand with pinacolborane. Subsequent ...